title: [The Medical Product Agency sharpens its control. What is the consequence of bad trials?].
authors.affiliation: Ansvarig för verksamheten med GCTP-inspektioner, Läkemedelsverket, Uppsala.
authors.forename: S W
authors.initials: SW
authors.lastname: Naeser
authors.forename: S
authors.initials: S
authors.lastname: Nordlund
mesh_terms: D002986:Clinical Trials as Topic; D017277:Drug Approval; D004335:Drug and Narcotic Control; D015871:Scientific Misconduct; D013548:Sweden
vernacular_title: Läkemedelsverket skärper tillsynen. Vad blir konsekvensen av dåliga prövningar?